SCHEMBL187080

SCHEMBL187080

CCCCC(CC)COC(=O)C(O)CO

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.60
TSHR P16473 3/20 0.60
TDP1 Q9NUW8 2/20 0.60
ATM Q13315 1/20 0.60
RECQL P46063 1/20 0.54
ALDH1A1 P00352 6/20 0.53
CA2 P00918 3/20 0.53
LMNA P02545 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
MAPK1 P28482 3/20 0.47
HSD17B10 Q99714 1/20 0.47
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP14 P50281 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL258068 0.86 LMNA (0.52) CYP3A4TSHRTDP1ATMLMNA
SCHEMBL10799754 0.86 LMNA (0.52) CYP3A4TSHRTDP1ATMLMNA
SCHEMBL6664875 0.86 LMNA (0.52) CYP3A4TSHRTDP1ATMLMNA
SCHEMBL15535463 0.85 LMNA (0.46) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL232146 0.85 CYP3A4 (0.58) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL1232704 0.84 CYP3A4 (0.66) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL1389534 0.83 CYP3A4 (0.57) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL475612 0.83 RECQL (0.67) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL7157460 0.83 TSHR (0.54) CYP3A4TSHRTDP1ATMRECQL
SCHEMBL7629758 0.83 CYP3A4 (0.60) CYP3A4TSHRTDP1ATMRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333686-A1 RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF GLYCERIC ACID AND DOWNSTREAM PRODUCTS LYGOS, INC. (US) 2025-10-30 US claimed
EP-3677246-B1 ANTIBACTERIAL ANTIFUNGAL COMPOSITION ADEKA CORP (JP) 2024-07-17 EP claimed
WO-2024127414-A1 A COSMETIC COMPOSITION FOR ACNE CONTROL AND METHODS THEREOF L'OREAL (FR) 2024-06-20 WO claimed
US-20240147989-A1 FLYING INSECT EXTERMINATION SPRAY KAO CORPORATION (JP) 2024-05-09 US claimed
CN-117750951-A Film-forming compositions comprising salicylic acid and methods of use 3M创新有限公司 2024-03-22 CN claimed
CN-116981358-A Spray for expelling flying insect pests 花王株式会社 2023-10-31 CN claimed
US-20230218641-A1 ANTI-ACNE COMPOSITIONS L'OREAL (FR) 2023-07-13 US claimed
CN-115916147-A Anti-acne composition 欧莱雅 2023-04-04 CN claimed
EP-4153127-A1 ANTI-ACNE COMPOSITIONS L'OREAL (FR) 2023-03-29 EP claimed
US-11395486-B2 Antibacterial and antifungal composition ADEKA CORPORATION (JP) 2022-07-26 US claimed
CN-102803461-A Liquid detergent composition KAO CORP 2012-11-28 CN claimed
CN-102686716-A Process for producing detergent particles KAO CORP 2012-09-19 CN claimed
CN-1990622-B Water-based ink for ink-jet recording KAO CORP 2012-04-25 CN claimed
US-20110282103-A1 PROCESS FOR THE PREPARATION OF POLYGLYCERYL ETHER DERIVATIVES KAO CORPORATION (JP) 2011-11-17 US claimed
US-8013053-B2 Water-based inks for ink-jet printing KAO CORPORATION (JP) 2011-09-06 US claimed
US-20080119527-A1 Composition for combating the localized hyperpigmentation of dark skin L'OREAL (FR) 2008-05-22 US claimed
US-7375067-B2 Liquid detergent composition comprising an anionic surfactant, amine oxide, and alkyl glyceryl ether KAO CORPORATION (JP) 2008-05-20 US claimed
EP-1589093-B1 LIQUID DETERGENT COMPOSITION KAO CORP (JP) 2006-12-13 EP claimed
US-20060105933-A1 Liquid detergent composition KAO CORPORATION (JP) 2006-05-18 US claimed
EP-1589093-A1 LIQUID DETERGENT COMPOSITION Kao Corporation (JP) 2005-10-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282103-A1 PROCESS FOR THE PREPARATION OF POLYGLYCERYL ETHER DERIVATIVES AGL, AGPAT2, GK CYP3A4 1525/4885TSHR 2788/4885TDP1 4659/4885
US-20230218641-A1 ANTI-ACNE COMPOSITIONS CUTA, EBP, ACMSD CYP3A4 4647/4885TSHR 4771/4885TDP1 2507/4885
US-11395486-B2 Antibacterial and antifungal composition ERG28, CYP51A1, UGCG CYP3A4 300/4885TSHR 4628/4885TDP1 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.